Open AccessNDM-1-Producing Acinetobacter baumannii from Algeria
Author(s) -
Anne Boulanger,
Thierry Naas,
Nicolas Fortineau,
Samy Figueiredo,
Patrice Nordmann
Publication year - 2012
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.05653-11
Subject(s) - acinetobacter baumannii , microbiology and biotechnology , acinetobacter , neisseriaceae , biology , medicine , virology , antibiotics , bacteria , genetics , pseudomonas aeruginosa
Over the last decade, nosocomial infections with Acinetobacter baumannii have been described with an increasing trend toward multidrug resistance, mostly in intensive care units (ICUs) ([6][1], [9][2], [11][3]). The main mechanism of resistance to carbapenems in A. baumannii is the production of
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom